This led to speculation that this hypertension-associated increased risk might, at least in part, be due to the most common drugs used to treat hypertension, notably; renin-angiotensin system (RAS) inhibitors, such as angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) [3–5]. This evidence concerns the gene REN and hypertensive disorder.